Stereoselective sulfation of albuterol in humans. Biosynthesis of the sulfate conjugate by HEP G2 cells
The objective of this study was to test the utility of the human hepatoma cell line Hep G2 for the biosynthesis of the sulfate conjugate of the beta 2-agonist drug albuterol and to determine the stereo-chemistry of the sulfation reaction. Albuterol was, together with Na(2)35SO4, incubated with Hep G...
Saved in:
Published in | Drug metabolism and disposition Vol. 21; no. 1; p. 76 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.01.1993
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | The objective of this study was to test the utility of the human hepatoma cell line Hep G2 for the biosynthesis of the sulfate conjugate of the beta 2-agonist drug albuterol and to determine the stereo-chemistry of the sulfation reaction. Albuterol was, together with Na(2)35SO4, incubated with Hep G2 cells for 48 hr at 37 degrees C. After precipitation of the inorganic sulfate and protein in the medium, the radiolabeled albuterol sulfate formed was isolated by reversed-phase HPLC. The structure of the sulfate conjugate was determined by liquid secondary ion MS and tandem MS, producing a clear molecular ion and a characteristic fragmentation pattern, respectively. The maximum yield from a 100 mm culture dish was 400 micrograms, sufficient for structure identification as well as for development of stereospecific methodology. Efforts to increase the yields by increasing inorganic sulfate or using dexamethasone as an inducer produced only modest effects. Resolution of the albuterol sulfate enantiomers by HPLC, after chiral derivatization, showed a clear preference for the sulfation of (-)-albuterol. This was also shown in kinetic experiments with the individual enantiomers, using cell homogenates, which gave apparent KM values of 115 microM and 528 microM for (-)- and (+)-albuterol, respectively, with an apparent Vmax value 1.7 times higher for (-)-albuterol. The efficiency of sulfation (Vmax/KM) was thus 7.8-fold higher for the pharmacologically more active (-)-enantiomer. Based on these observations, considerably higher bioavailability of (+)- than of (-)-albuterol may be anticipated after oral or inhaled doses of this drug. |
---|---|
AbstractList | The objective of this study was to test the utility of the human hepatoma cell line Hep G2 for the biosynthesis of the sulfate conjugate of the beta 2-agonist drug albuterol and to determine the stereo-chemistry of the sulfation reaction. Albuterol was, together with Na(2)35SO4, incubated with Hep G2 cells for 48 hr at 37 degrees C. After precipitation of the inorganic sulfate and protein in the medium, the radiolabeled albuterol sulfate formed was isolated by reversed-phase HPLC. The structure of the sulfate conjugate was determined by liquid secondary ion MS and tandem MS, producing a clear molecular ion and a characteristic fragmentation pattern, respectively. The maximum yield from a 100 mm culture dish was 400 micrograms, sufficient for structure identification as well as for development of stereospecific methodology. Efforts to increase the yields by increasing inorganic sulfate or using dexamethasone as an inducer produced only modest effects. Resolution of the albuterol sulfate enantiomers by HPLC, after chiral derivatization, showed a clear preference for the sulfation of (-)-albuterol. This was also shown in kinetic experiments with the individual enantiomers, using cell homogenates, which gave apparent KM values of 115 microM and 528 microM for (-)- and (+)-albuterol, respectively, with an apparent Vmax value 1.7 times higher for (-)-albuterol. The efficiency of sulfation (Vmax/KM) was thus 7.8-fold higher for the pharmacologically more active (-)-enantiomer. Based on these observations, considerably higher bioavailability of (+)- than of (-)-albuterol may be anticipated after oral or inhaled doses of this drug. |
Author | Walle, U K Walle, T Schey, K L Thornburg, K R |
Author_xml | – sequence: 1 givenname: T surname: Walle fullname: Walle, T organization: Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston 29425 – sequence: 2 givenname: U K surname: Walle fullname: Walle, U K – sequence: 3 givenname: K R surname: Thornburg fullname: Thornburg, K R – sequence: 4 givenname: K L surname: Schey fullname: Schey, K L |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/8095231$$D View this record in MEDLINE/PubMed |
BookMark | eNotT91qwjAYzYXDqdsjDPICHWl-WnO5idOBsIHuWpL0i42kiTTtoG-_ynp1zuH8wFmiWYgBZmhBiCSZFKJ4RMuUroTknDM5R_M1kYKyfIEuxw5aiAk8mM79Ak69t6pzMeBosfK6H_3osQu47hsV0it-dzENoashuXQPjWxqATYxXPvLnekB77ffeEexAe_TE3qwyid4nnCFfj62p80-O3ztPjdvh6ymBe-yQrJcgKrWUBIqwHALgtGSGKU0yGKUjLGSW1kYXVHKaT4-ZAYYSMlVWdEVevnfvfW6gep8a12j2uE8HaZ_YOVTrg |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
ExternalDocumentID | 8095231 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: GM 46000 |
GroupedDBID | --- .GJ 0R~ 18M 2WC 4.4 53G 5GY 5RE 5VS ABJNI ABSQV ACGFO ACGFS ACIWK ACPRK ADBBV AENEX AERNN AFFNX AFOSN AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P F9R FRP GX1 H13 HZ~ IH2 INIJC KQ8 LSO NPM O9- OK1 P2P R0Z RHF RHI RPT SJN TR2 VH1 W2D W8F WH7 WOQ YCJ YHG ZGI ZXP ~KM |
ID | FETCH-LOGICAL-h264t-69315ead8e7025ec4fe53270caabe964fe33374f96cbd224210903ce3e994a7d2 |
ISSN | 0090-9556 |
IngestDate | Sat Sep 28 07:32:31 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-h264t-69315ead8e7025ec4fe53270caabe964fe33374f96cbd224210903ce3e994a7d2 |
PMID | 8095231 |
ParticipantIDs | pubmed_primary_8095231 |
PublicationCentury | 1900 |
PublicationDate | 1993 Jan-Feb |
PublicationDateYYYYMMDD | 1993-01-01 |
PublicationDate_xml | – month: 01 year: 1993 text: 1993 Jan-Feb |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Drug metabolism and disposition |
PublicationTitleAlternate | Drug Metab Dispos |
PublicationYear | 1993 |
SSID | ssj0014439 |
Score | 1.6214871 |
Snippet | The objective of this study was to test the utility of the human hepatoma cell line Hep G2 for the biosynthesis of the sulfate conjugate of the beta 2-agonist... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 76 |
SubjectTerms | Albuterol - metabolism Chromatography, High Pressure Liquid - methods Culture Media Humans Kinetics Liver Neoplasms - metabolism Mass Spectrometry Stereoisomerism Sulfates - metabolism Tumor Cells, Cultured |
Title | Stereoselective sulfation of albuterol in humans. Biosynthesis of the sulfate conjugate by HEP G2 cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/8095231 |
Volume | 21 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYKVSUuFX2gQh_yAXGBoGzs2PGxaimrSqCV2JW4ocQeAxVNENk9bH99xw-SdAtV20sUxckq8vdl_Hl2HoTsSsGtFswkWgie4ArNkjItTJJDJaVIrZW-1-HJqRjP-Nfz_LzPPfHZJfPqUP94MK_kf1DFa4iry5L9B2S7H8ULeI744hERxuNfYXyGkwJN61vZuAigdnFjOwnoAo9xvHFFNUIrvvbQtZ5slzWKvliHxMnO8JSPWv-2cF41J0nHR5P942zf-fXboYD9fLe4dG2nkTs39_01zHUX-zX0z8MvMdjdlVnvWZ1eNXe-9II3N33s4hkyKYQTxKQIE_P02MAtEU2tShOVh6rh96Y2G_1GqWA3Qw-YAWS33z1mBSrALCwTfxxcqZkdR9bImiyc2Tt1Lpz41xLnLOyJ4vttkGfx9pWdhVcY003yPG4N6MeA8wvyBOqXZG8SaosvD-i0T5VrD-genfRVx5evyOUKGWhHBtpY2pGBXtc0koEOyeBuwrP4FNCODLRaUiQDPc6oJ8NrMvtyNP00TmIXjeQKxe48EYqNcrQXBUjUt6C5hZxlMtVlWYHCTxUYY5JbJXRlMhch4Fx3GhgoxUtpsi2yXjc1vCE0lymMmNF6ZDJui1IB5EIZiwuDTouq2CZbYQIvbkOplIs4szuPDbwlGz153pGnFr9MeI8yb1598LD9BP22WC8 |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stereoselective+sulfation+of+albuterol+in+humans.+Biosynthesis+of+the+sulfate+conjugate+by+HEP+G2+cells&rft.jtitle=Drug+metabolism+and+disposition&rft.au=Walle%2C+T&rft.au=Walle%2C+U+K&rft.au=Thornburg%2C+K+R&rft.au=Schey%2C+K+L&rft.date=1993-01-01&rft.issn=0090-9556&rft.volume=21&rft.issue=1&rft.spage=76&rft_id=info%3Apmid%2F8095231&rft_id=info%3Apmid%2F8095231&rft.externalDocID=8095231 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-9556&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-9556&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-9556&client=summon |